000178603 001__ 178603
000178603 005__ 20240229143550.0
000178603 0247_ $$2doi$$a10.1016/j.molcel.2021.12.028
000178603 0247_ $$2pmid$$apmid:35063091
000178603 0247_ $$2ISSN$$a1097-2765
000178603 0247_ $$2ISSN$$a1097-4164
000178603 0247_ $$2altmetric$$aaltmetric:121284828
000178603 037__ $$aDKFZ-2022-00152
000178603 041__ $$aEnglish
000178603 082__ $$a610
000178603 1001_ $$aMaschmeyer, Patrick$$b0
000178603 245__ $$aATACing single cells with phages.
000178603 260__ $$aNew York, NY$$bElsevier$$c2022
000178603 3367_ $$2DRIVER$$aarticle
000178603 3367_ $$2DataCite$$aOutput Types/Journal article
000178603 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1646916714_14581
000178603 3367_ $$2BibTeX$$aARTICLE
000178603 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000178603 3367_ $$00$$2EndNote$$aJournal Article
000178603 500__ $$a#LA:A010#
000178603 520__ $$aFiskin et al. (2021) developed a 'multi-omics' approach that integrates phage-displayed single-domain antibodies ('nanobodies') with the assay for transposase-accessible chromatin (PHAGE-ATAC) to simultaneously determine protein expression, chromatin accessibility, and mitochondrial DNA mutations (for clonal tracing) in single cells.
000178603 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000178603 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000178603 7001_ $$0P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325$$aHaas, Simon$$b1$$eLast author$$udkfz
000178603 773__ $$0PERI:(DE-600)2001948-8$$a10.1016/j.molcel.2021.12.028$$gVol. 82, no. 2, p. 234 - 236$$n2$$p234 - 236$$tMolecular cell$$v82$$x1097-2765$$y2022
000178603 909CO $$ooai:inrepo02.dkfz.de:178603$$pVDB
000178603 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a5ec4e2fef99022a37a6b07c2fdd6325$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000178603 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000178603 9141_ $$y2022
000178603 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000178603 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000178603 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000178603 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bMOL CELL : 2021$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2022-11-17
000178603 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bMOL CELL : 2021$$d2022-11-17
000178603 9202_ $$0I:(DE-He78)A010-20160331$$kA010$$lA010 Stammzellen und Krebs$$x0
000178603 9201_ $$0I:(DE-He78)A010-20160331$$kA010$$lA010 Stammzellen und Krebs$$x0
000178603 9201_ $$0I:(DE-He78)V960-20160331$$kV960$$lV960 HI-Stem$$x1
000178603 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000178603 980__ $$ajournal
000178603 980__ $$aVDB
000178603 980__ $$aI:(DE-He78)A010-20160331
000178603 980__ $$aI:(DE-He78)V960-20160331
000178603 980__ $$aI:(DE-He78)HD01-20160331
000178603 980__ $$aUNRESTRICTED